Sofgen Pharma S.A. (PROCF)
OTCMKTS · Delayed Price · Currency is USD
0.0251
0.00 (0.00%)
Jul 24, 2026, 9:30 AM EST

Sofgen Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Jan '22 Dec '20
Net Income
-68.340.3436.13-106.99-10.45
Depreciation & Amortization
15.7114.6716.8415.1116.48
Other Amortization
4.333.53---
Loss (Gain) From Sale of Assets
5.240.620.64-0.480.3
Asset Writedown & Restructuring Costs
1.9813.756.02--
Loss (Gain) From Sale of Investments
-12.65-11.19-61.8-4.51-
Loss (Gain) on Equity Investments
0.49-0.50.920.31-0.81
Provision & Write-off of Bad Debts
3.362.932.67-0.82-1.92
Other Operating Activities
52.1619.8236.2164.3553.18
Change in Accounts Receivable
35.56-5.57-10.8-15.621.89
Change in Inventory
-2.386.59-34.11-20.43-0.9
Change in Accounts Payable
38.3832.51-3020.9811.8
Change in Income Taxes
2.55-3.64-5.81-3.63-2.58
Change in Other Net Operating Assets
11.99-6.2158.65-12.813.93
Operating Cash Flow
88.43107.6415.5535.4570.92
Operating Cash Flow Growth
-17.84%592.19%-56.14%-50.01%3.86%

Investing Activities

Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Jan '22 Dec '20
Capital Expenditures
-19.38-20.33-23.16-15.44-7.7
Sale of Property, Plant & Equipment
0.04-1.680.950.63
Sale (Purchase) of Intangibles
-5.64-12.46-10.96-10.4-10.22
Other Investing Activities
-1.79-1.840.060.030.2
Investing Cash Flow
-26.76-34.63-32.38-24.86-17.09

Financing Activities

Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Jan '22 Dec '20
Short-Term Debt Issued
--0.06-0.03
Long-Term Debt Issued
86.6883.25136.26280.79106.74
Total Debt Issued
86.6883.25136.32280.79106.77
Short-Term Debt Repaid
---7.19-9.15-5.86
Long-Term Debt Repaid
-141.32-143.95-131.6-281.16-126.32
Total Debt Repaid
-141.32-143.95-138.79-290.31-132.18
Net Debt Issued (Repaid)
-54.64-60.69-2.47-9.52-25.41
Issuance of Common Stock
38.61----
Repurchase of Common Stock
-0.82-2.18--45-
Other Financing Activities
-33.56-34.95-10.33112.36-15.1
Financing Cash Flow
-50.4-97.83-12.857.84-40.51

Net Cash Flow

Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Jan '22 Dec '20
Foreign Exchange Rate Adjustments
1.54-0.670.52-0.56-11.13
Net Cash Flow
12.8-25.49-29.1167.882.19

Free Cash Flow

Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Jan '22 Dec '20
Free Cash Flow
69.0587.3-7.6120.0263.22
Free Cash Flow Growth
-20.90%---68.34%11.93%
Free Cash Flow Margin
18.47%20.60%-1.89%4.96%19.07%
Free Cash Flow Per Share
0.690.86-0.070.200.65
Levered Free Cash Flow
20.9213.1-52.35-21.16-28.65
Unlevered Free Cash Flow
47.4738.63-36.232.334.25

Additional Metrics

Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Jan '22 Dec '20
Cash Interest Paid
33.5634.8310.0317.4316.94
Cash Income Tax Paid
10.465.477.3111.5613.14
Change in Working Capital
86.123.68-22.07-31.5114.13